Kayitalire Louis 4
4 · F-star Therapeutics, Inc. · Filed Jul 7, 2021
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-07-02$8.43/sh−1,054$8,885→ 54,383 total
Footnotes (2)
- [F1]Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
- [F2]Includes 48,828 restricted stock units.